Table 2 The outcomes of PCOS women in ovulation induction with or without vitamin E
Group A (n = 110) | Group B (n = 105) | Group C (n = 106) | |
|---|---|---|---|
Total cyclc | 345 | 292 | 328 |
HMG dosage (75 IU/bottle) | 6.62 ± 2.37 | 5.29 ± 2.35*△ | 6.43 ± 2.44 |
No. of dominant follicles (≥18 mm) | 1.44 ± 0.89 | 1.30 ± 0.74 | 1.50 ± 0.88 |
Data on day of HCG administration | |||
 Endometrium thickness (mm) | 7.38 ± 1.43 | 8.33 ± 1.19*△ | 7.76 ± 2.03 |
  Mean total E2 (pg/ml) | 245.23 ± 126.74 | 336.51 ± 155.62*△ | 214.92 ± 114.11 |
 Mean E2 per mature follicle(pg/ml) | 162.55 ± 60.40 | 261.81 ± 92.88*△ | 146.61 ± 88.51 |
Ovulation rate | 85 (77.3%) | 75 (71.43%) | 78 (73.6%) |
No. of ovulations/total cycles | 85/345(24.6%) | 75/292(25.7%) | 78/328(23.8%) |
Clinical pregnancy rate | 31 (28.2%) | 29 (27.6%) | 25 (23.6%) |
Ongoing pregnancy rate | 27 (24.5%) | 29 (27.6%) | 24 (22.6%) |